Stanley Lee, PhD

Faculty Member

Stanley Lee, PhD

Assistant Professor
Translational Science and Therapeutics Division, Fred Hutch

Immunotherapy Integrated Research Center (IIRC), Fred Hutch

Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Fax: 206.667.2917
Mail Stop: D4-100

Dr. Stanley Lee studies the molecular basis of blood cell development and how its dysregulation can lead to hematologic malignancies such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research focuses on defining how disease-causing mutations impact the biology of hematopoietic stem and progenitor cells, and how they drive disease progression and response to therapy. The ultimate goal of Dr. Lee’s research is to translate this knowledge into novel treatments for patients with blood-related disorders including leukemia.


Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center, 2014-2019

PhD, Walter and Eliza Hall Institute of Medical Research, 2012

MSc (Hons), University of Auckland, 2007

BSc (Hons), University of Auckland, 2005

Research Interests

Understanding and targeting altered RNA processing in hematologic malignancies

Epigenetic regulation of normal and malignant hematopoiesis

Identification and development of novel therapeutic approaches to hematologic malignancies

"I really started to understand that to have the most impactful experiment, you don’t have to have the perfect design. Science doesn’t always have to be beautiful or perfect. It’s even more important to be timely."

— Dr. Stanley Lee

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210